BioSig Expands Its Clinical Footprint In Florida

NEXT STORY
Kura Oncology Doses First Patient in Phase 1/2 Clinical Trial of Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma
PREV STORY
GRSi Wins a Three-Year Contract to Provide Extramural Division Analysis and Environmental Assessment Support to NIDDK
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chiasma to Present Encore and New Data from MPOWERED™ Phase 3 Trial at Upcoming e-ECE and AACE Virtual Conferences

author_avatar
NASDAQ Market News

PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in Overcoming a Major Limitation of Immuno-Oncology

author_avatar
NASDAQ Market News

Diffusion Pharmaceuticals Reports Final Results from Its Phase 1b Study of Trans Sodium Crocetinate in Hospitalized COVID-19 Patients

author_avatar
NASDAQ Market News